Perelel Prenatal Supplements vs. Generic Prenatal Supplements and Health of Mother and Baby (SUPPORT)
NCT ID: NCT07046845
Last Updated: 2026-01-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
600 participants
INTERVENTIONAL
2026-01-31
2027-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main question it aims to answer is:
• How does taking Perelel prenatal supplements versus generic prenatal supplements during pregnancy change the nutritional markers in blood samples?
Participants will:
* Take either Perelel or generic prenatal supplements daily throughout pregnancy
* Visit UPMC Magee-Womens Hospital once every trimester of pregnancy for blood draws and answering questionnaires
In an observational part of this study for different participants, researchers will use blood tests and questionnaires only once during the first trimester to compare pregnant women without food insecurity to those with food insecurity.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pregnancy Outcome and Vitamin D Level Among Vitamin D Supplementation During Pregnancy
NCT04591847
Prenatal Nutrient Status Study
NCT06156826
Oral Progesterone and Low Dose Aspirin in the Prevention of Preeclampsia
NCT00719537
Combined Antioxidant and Preeclampsia Prediction Studies (CAPPS)
NCT00135707
L-Arginine and Antioxidant Vitamins During Pregnancy to Reduce Preeclampsia
NCT00469846
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Perelel Prenatal Supplement Group
Perelel Prenatal Vitamin
Daily Perelel prenatal vitamin supplement throughout pregnancy
Generic Prenatal Supplement Group
Generic Prenatal Vitamin
Daily generic prenatal vitamin supplement throughout pregnancy.
Observational Arm
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Perelel Prenatal Vitamin
Daily Perelel prenatal vitamin supplement throughout pregnancy
Generic Prenatal Vitamin
Daily generic prenatal vitamin supplement throughout pregnancy.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Identify as having food insecurity
3. Receiving care at a Magee-Womens Hospital associated prenatal practice
4. Less than 12 weeks' of pregnancy
Exclusion Criteria
2. Unborn baby (fetus) identified as having a chromosomal or structural defect
3. Have a condition that prevents absorption of nutrients from food
4. History of medically treated thyroid disorder
5. Ongoing steroid use
14 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Perelel Inc.
INDUSTRY
University of Pittsburgh
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hyagriv Simhan
Professor & Executive Vice Chair, OB/GYN/RS, Director, Clinical Innovation in Women's Health, UPMC
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hyagriv Simhan, MD
Role: PRINCIPAL_INVESTIGATOR
Magee-Women's Research Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UPMC Magee-Womens Hospital
Pittsburgh, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY25020013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.